Court Selects 10 Paraquat Lawsuits For Second Round of Bellwether Trial Discovery

Paraquat Weed Killer

The U.S. District Judge presiding over all Paraquat lawsuits has selected a new group of 10 bellwether claims to go through case-specific discovery and preparations for a series of test trials, after a first group of four bellwether cases were all dismissed earlier this year.

There are currently 6,000 product liability lawsuits pending in the federal court system against the manufacturers of the controversial weedkiller, each raising similar allegations that Syngenta and Chevron failed to adequately disclose the link between Paraquat and Parkisonโ€™s disease.

Given common questions of fact and law raised in claims brought by individuals diagnosed with the devastating neurological disease after routinely spraying, mixing or transporting the weedkiller, theย Paraquat lawsuits have been centralizedย before U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois since June 2021, as part of a federal MDL, or multidistrict litigation.

To help the parties evaluate how juries may respond to certain evidence and testimony that will be repeated throughout various claims, the Court previously established a โ€œbellwetherโ€ process whereย a small group ofย Paraquat lawsuits were prepared for trial. However, Judge Rosenstengel dismissed those cases in April, after excluding the plaintiffs’ designated expert witnesses from testify at trial, leaving those claimants without any means to establish that their Parkinson’s disease diagnosis was caused by Paraquat.

Following the dismissal of the first batch of proposed Paraquat bellwether cases, Judge Rosenstengel expressed the Court’s intention to “expeditiously identify a new set of trial cases and set a tight schedule for limited discovery and trial,” to determine whether other experts can offer reliable testimony establishing causation.

On Tuesday, a court order (PDF) was issued announcing the selection of the 10 new Paraquat lawsuits that will undergo case-specific discovery as part of a new bellwether trial pool.

The parties have until August 20, 2024 to voluntarily dismiss any of the selected cases without prejudice, which will give the court time to select a replacement claim. Once the final group is confirmed, plaintiffs selected will have until September 3 to provide defendants with a completed Fact Sheet, with depositions taking place by November 25. The order calls for the parties to submit a one-page summary to the Court on each selected case by December 16, 2024.

The selected cases all include claims that Paraquat exposure led to serious health consequences. One complaint, filed by Susan Benavidez (PDF) of Illinois, indicates that she used Paraquat for 27 years, leading to a Parkinsonโ€™s disease diagnosis in 2018. Another claim filed by Michael Peek (PDF), of Alabama, makes almost identical claims that he developed Parkinsonโ€™s disease after being exposed to Paraquat for years while working in Indiana.

It is believed these lawsuits rely on different expert witness testimony than the previously dismissed claims, utilizing different methods to establish the link between Paraquat and Parkinsonโ€™s disease.

In addition, a large number of Paraquat cases are currently pending in various different state courts, which have different evidentiary standards for the admissibility of expert witness testimony. Following the bellwether trials, if Syngenta and Chevron are unable to negotiate a global Paraquat settlement agreement, thousands of claims are likely to be remanded back to their originating districts for individual trial dates.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An Illinois man alleges he was implanted with a defectively designed Medtronic spinal cord stimulator that was later adjusted by company sales representatives who were not medically trained.
A Pennsylvania woman says she suffered hearing loss and other long-term Depo-Provera side effects after receiving the birth control injections for nearly 20 years.
A federal judge has put in place additional procedures to address the deaths of women suffering from cancer who are pursuing hair relaxer lawsuits, allowing estates and families to take up their claims.